Fortrea Holdings Inc. (FTRE)
NASDAQ: FTRE · Real-Time Price · USD
19.54
-0.89 (-4.38%)
Sep 23, 2026, 4:00 PM EDT - Market closed
Fortrea Holdings Revenue
Fortrea Holdings had revenue of $678.20M in the quarter ending June 30, 2026, a decrease of -4.52%. This brings the company's revenue in the last twelve months to $2.68B, down -2.09% year-over-year. In the year 2025, Fortrea Holdings had annual revenue of $2.72B with 1.00% growth.
Revenue (ttm)
$2.68B
Revenue Growth
-2.09%
P/S Ratio
0.69
Revenue / Employee
$191,179
Employees
14,000
Market Cap
1.86B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.72B | 27.00M | 1.00% |
| Dec 31, 2024 | 2.70B | -146.10M | -5.14% |
| Dec 31, 2023 | 2.84B | 5.50M | 0.19% |
| Dec 31, 2022 | 2.84B | -220.50M | -7.21% |
| Dec 31, 2021 | 3.06B | 477.20M | 18.49% |
| Dec 31, 2020 | 2.58B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Lakefront Biotherapeutics NV | 1.13B |
| Vir Biotechnology | 303.23M |
| Mesoblast | 120.25M |
| Xencor | 104.97M |
| Zymeworks | 37.13M |
| Stoke Therapeutics | 27.59M |
FTRE News
- 8 days ago - Fortrea Holdings Transcript: 2026 Global Healthcare Conference - Transcripts
- 12 days ago - Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 13 days ago - Fortrea to Participate in September Investor Conferences - GlobeNewsWire
- 21 days ago - Fortrea to buy Worldwide Clinical Trials Early Phase Services division for $45M - TheFly
- 21 days ago - Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials - GlobeNewsWire
- 7 weeks ago - Fortrea price target raised to $23 from $19 at TD Cowen - TheFly
- 7 weeks ago - Fortrea price target raised to $22 from $20 at Citi - TheFly
- 7 weeks ago - Fortrea price target raised to $20 from $18 at Deutsche Bank - TheFly